Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 12;134(11):1259-1264.
doi: 10.1042/CS20200492.

Covid-19: the renin-angiotensin system imbalance hypothesis

Katharina Lanza  1 , Lucas G Perez  1 , Larissa B Costa  1 , Thiago M Cordeiro  1 , Vitria A Palmeira  1 , Victor T Ribeiro  1 , Ana Cristina Simões E Silva  1
Affiliations
Review

Covid-19: the renin-angiotensin system imbalance hypothesis

Katharina Lanza et al. Clin Sci (Lond). .

Abstract

The emergency of SARS-CoV-2 in China started a novel challenge to the scientific community. As the virus turns pandemic, scientists try to map the cellular mechanisms and pathways of SARS-CoV-2 related to the pathogenesis of Coronavirus Disease 2019 (Covid-19). After transmembrane angiotensin-converting enzyme 2 (ACE2) has been found to be SARS-CoV-2 receptor, we hypothesized an immune-hematological mechanism for Covid-19 based on renin-angiotensin system (RAS) imbalance to explain clinical, laboratory and imaging findings on disease course. We believe that exaggerated activation of ACE/Angiotensin II (Ang II)/Angiotensin Type 1 (AT1) receptor RAS axis in line with reduction of ACE2/Angiotensin-(1-7)/Mas receptor may exert a pivotal role in the pathogenesis of Covid-19. In this perspective, we discuss potential mechanisms and evidence on this hypothesis.

Keywords: Angiotensin-Converting Enzyme 2; Covid-19; Renin-Angiotensin System; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. Pathophysiological role of ACE2 in COVID-19
Schematic representation of pathophysiological mechanisms related to COVID-19 and the overlapping pathways with renin–angiotensin system, particularly with the modulation of ACE2. [O2] = Oxygen concentration; HS = Hemophagocytic-like Syndrome; ACE2 = Angiotensin-Converting Enzyme 2; ANG(1-7) = Angiotensin (1-7); ANGII = Angiotensin II; HPSC = Hematopoietic stem/progenitor cell.
Figure 2
Figure 2. ACE2 basis for age specific differences in COVID-19 outcome
Schematic representation of the differences detected in ACE2 expression according to age. The figure highlights the hypothetical mechanisms related to COVID-19 outcome based on the protective effects of free ACE2 for buffering the viral infection as well as reducing inflammation. ACE2, angiotensin-converting enzyme 2; ANG(1-7), angiotensin (1-7); ANGII, Angiotensin II.
See this image and copyright information in PMC

References

    1. Touyz R., Li H. and Delles C. (2020) ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Clin. Sci. 134, 747–750 10.1042/CS20200363 - DOI - PubMed
    1. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J. et al. . (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 10.1056/NEJMoa2002032 - DOI - PMC - PubMed
    1. Nair H., Nokes D., Gessner B., Dherani M., Madhi S., Singleton R. et al. . (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet North Am. Ed. 375, 1545–1555 10.1016/S0140-6736(10)60206-1 - DOI - PMC - PubMed
    1. Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z. et al. . (2020) Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell 181, 894.e9–904.e9 10.1016/j.cell.2020.03.045 - DOI - PMC - PubMed
    1. Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H. et al. . (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224 10.1038/s41586-020-2179-y - DOI - PMC - PubMed

MeSH terms

Substances